

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | leukocyte aggregation (GO:0070486) | 5.14506208 |
| 2 | positive regulation of gamma-delta T cell activation (GO:0046645) | 5.01265518 |
| 3 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.80954264 |
| 4 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.80954264 |
| 5 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.67852244 |
| 6 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.49737785 |
| 7 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 4.40243530 |
| 8 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.35482421 |
| 9 | negative regulation of phagocytosis (GO:0050765) | 4.32672111 |
| 10 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 4.32510881 |
| 11 | ribosomal small subunit assembly (GO:0000028) | 4.30552678 |
| 12 | positive T cell selection (GO:0043368) | 4.18369770 |
| 13 | positive regulation of B cell differentiation (GO:0045579) | 3.79995125 |
| 14 | mast cell activation (GO:0045576) | 3.78751709 |
| 15 | respiratory burst (GO:0045730) | 3.74650562 |
| 16 | neutrophil activation involved in immune response (GO:0002283) | 3.73402980 |
| 17 | regulation of B cell differentiation (GO:0045577) | 3.70191566 |
| 18 | T cell selection (GO:0045058) | 3.69962400 |
| 19 | cellular response to zinc ion (GO:0071294) | 3.69105336 |
| 20 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.65988120 |
| 21 | immunoglobulin mediated immune response (GO:0016064) | 3.65183818 |
| 22 | detection of bacterium (GO:0016045) | 3.64223105 |
| 23 | detection of other organism (GO:0098543) | 3.58401572 |
| 24 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.55768684 |
| 25 | cytidine metabolic process (GO:0046087) | 3.53922711 |
| 26 | cytidine catabolic process (GO:0006216) | 3.53922711 |
| 27 | cytidine deamination (GO:0009972) | 3.53922711 |
| 28 | T cell migration (GO:0072678) | 3.48074322 |
| 29 | positive regulation by symbiont of host defense response (GO:0052509) | 3.42417140 |
| 30 | modulation by symbiont of host defense response (GO:0052031) | 3.42417140 |
| 31 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.42417140 |
| 32 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.42417140 |
| 33 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.42417140 |
| 34 | modulation by symbiont of host immune response (GO:0052553) | 3.42417140 |
| 35 | B cell receptor signaling pathway (GO:0050853) | 3.40452753 |
| 36 | regulation of gamma-delta T cell activation (GO:0046643) | 3.36194826 |
| 37 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.33760828 |
| 38 | response to peptidoglycan (GO:0032494) | 3.31379064 |
| 39 | negative regulation of interleukin-12 production (GO:0032695) | 3.31124188 |
| 40 | positive regulation of granulocyte differentiation (GO:0030854) | 3.30797239 |
| 41 | regulation of antigen processing and presentation (GO:0002577) | 3.29874566 |
| 42 | positive regulation of antigen processing and presentation (GO:0002579) | 3.29783027 |
| 43 | defense response to protozoan (GO:0042832) | 3.29741447 |
| 44 | regulation of regulatory T cell differentiation (GO:0045589) | 3.29487909 |
| 45 | neutrophil mediated immunity (GO:0002446) | 3.29388914 |
| 46 | negative T cell selection (GO:0043383) | 3.28764898 |
| 47 | negative thymic T cell selection (GO:0045060) | 3.27681146 |
| 48 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 3.25358181 |
| 49 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.21997428 |
| 50 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 3.20762009 |
| 51 | regulation of natural killer cell mediated immunity (GO:0002715) | 3.20762009 |
| 52 | regulation of T cell tolerance induction (GO:0002664) | 3.20343284 |
| 53 | regulation of T cell mediated cytotoxicity (GO:0001914) | 3.18751547 |
| 54 | actin nucleation (GO:0045010) | 3.17448041 |
| 55 | response to protozoan (GO:0001562) | 3.16996985 |
| 56 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 3.15849573 |
| 57 | T cell receptor signaling pathway (GO:0050852) | 3.14012938 |
| 58 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 3.13309509 |
| 59 | Peyers patch development (GO:0048541) | 3.12051143 |
| 60 | mucosal-associated lymphoid tissue development (GO:0048537) | 3.12051143 |
| 61 | B cell mediated immunity (GO:0019724) | 3.11818375 |
| 62 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.11126784 |
| 63 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.08163516 |
| 64 | interferon-gamma production (GO:0032609) | 3.07449573 |
| 65 | regulation of tolerance induction (GO:0002643) | 3.07063076 |
| 66 | negative regulation of T cell mediated immunity (GO:0002710) | 3.07004872 |
| 67 | negative regulation of cell killing (GO:0031342) | 3.06129064 |
| 68 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.06129064 |
| 69 | cellular extravasation (GO:0045123) | 3.05216646 |
| 70 | modulation of growth of symbiont involved in interaction with host (GO:0044144) | 3.05191716 |
| 71 | regulation of growth of symbiont in host (GO:0044126) | 3.05191716 |
| 72 | negative regulation of growth of symbiont in host (GO:0044130) | 3.05191716 |
| 73 | negative regulation of growth of symbiont involved in interaction with host (GO:0044146) | 3.05191716 |
| 74 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 3.04994096 |
| 75 | positive thymic T cell selection (GO:0045059) | 3.04165497 |
| 76 | positive regulation of lamellipodium assembly (GO:0010592) | 3.04095708 |
| 77 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 3.03507551 |
| 78 | negative regulation of T cell apoptotic process (GO:0070233) | 3.02576322 |
| 79 | regulation of mast cell degranulation (GO:0043304) | 2.99919897 |
| 80 | sequestering of actin monomers (GO:0042989) | 2.98030383 |
| 81 | T cell costimulation (GO:0031295) | 2.98010629 |
| 82 | response to fungus (GO:0009620) | 2.97807378 |
| 83 | DNA deamination (GO:0045006) | 2.97355788 |
| 84 | regulation of T cell receptor signaling pathway (GO:0050856) | 2.97329474 |
| 85 | myeloid dendritic cell activation (GO:0001773) | 2.94972636 |
| 86 | telomere maintenance via semi-conservative replication (GO:0032201) | 2.94934108 |
| 87 | neutrophil activation (GO:0042119) | 2.94086332 |
| 88 | lymphocyte costimulation (GO:0031294) | 2.94001003 |
| 89 | regulation of leukocyte mediated cytotoxicity (GO:0001910) | 2.92993211 |
| 90 | positive regulation of leukocyte mediated cytotoxicity (GO:0001912) | 2.92418641 |
| 91 | response to interferon-beta (GO:0035456) | 2.90423054 |
| 92 | megakaryocyte development (GO:0035855) | 2.90092730 |
| 93 | response to type I interferon (GO:0034340) | 2.89494939 |
| 94 | type I interferon signaling pathway (GO:0060337) | 2.88500221 |
| 95 | cellular response to type I interferon (GO:0071357) | 2.88500221 |
| 96 | T cell homeostasis (GO:0043029) | 2.87876946 |
| 97 | cellular response to interferon-beta (GO:0035458) | 2.86882598 |
| 98 | defense response to fungus (GO:0050832) | 2.86258023 |
| 99 | positive regulation of tolerance induction (GO:0002645) | 2.85249915 |
| 100 | regulation of mast cell activation (GO:0033003) | 2.84826108 |
| 101 | positive regulation of mast cell activation (GO:0033005) | 2.84802442 |
| 102 | response to interleukin-15 (GO:0070672) | 2.84763403 |
| 103 | leukocyte cell-cell adhesion (GO:0007159) | 2.84395359 |
| 104 | disruption of cells of other organism involved in symbiotic interaction (GO:0051818) | 2.84239417 |
| 105 | killing of cells in other organism involved in symbiotic interaction (GO:0051883) | 2.84239417 |
| 106 | macrophage activation involved in immune response (GO:0002281) | 2.83229774 |
| 107 | tolerance induction (GO:0002507) | 2.82457471 |
| 108 | mast cell activation involved in immune response (GO:0002279) | 2.82134441 |
| 109 | mast cell degranulation (GO:0043303) | 2.82134441 |
| 110 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 2.82111318 |
| 111 | negative regulation of innate immune response (GO:0045824) | 2.81228441 |
| 112 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.80345534 |
| 113 | response to host immune response (GO:0052572) | 2.78656383 |
| 114 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.78656383 |
| 115 | regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045091 | 2.78239559 |
| 116 | DNA strand elongation involved in DNA replication (GO:0006271) | 2.77389038 |
| 117 | cellular response to interleukin-15 (GO:0071350) | 2.77128572 |
| 118 | leukocyte degranulation (GO:0043299) | 2.76732157 |
| 119 | positive regulation of isotype switching (GO:0045830) | 2.72816253 |
| 120 | myeloid leukocyte mediated immunity (GO:0002444) | 2.70099934 |
| 121 | angiogenesis involved in wound healing (GO:0060055) | 2.69286764 |
| 122 | DNA strand elongation (GO:0022616) | 2.69026793 |
| 123 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 2.67508386 |
| 124 | granulocyte activation (GO:0036230) | 2.67030637 |
| 125 | telomere maintenance via recombination (GO:0000722) | 2.66280076 |
| 126 | myeloid cell activation involved in immune response (GO:0002275) | 2.66100817 |
| 127 | antigen receptor-mediated signaling pathway (GO:0050851) | 2.63499614 |
| 128 | viral transcription (GO:0019083) | 2.60426008 |
| 129 | necroptotic process (GO:0070266) | 2.59073882 |
| 130 | leukocyte mediated cytotoxicity (GO:0001909) | 2.58554415 |
| 131 | NIK/NF-kappaB signaling (GO:0038061) | 2.57655192 |
| 132 | regulation of response to interferon-gamma (GO:0060330) | 2.56800111 |
| 133 | negative regulation of antigen receptor-mediated signaling pathway (GO:0050858) | 2.56496921 |
| 134 | lymphocyte homeostasis (GO:0002260) | 2.56172524 |
| 135 | positive regulation of macrophage differentiation (GO:0045651) | 2.55134027 |
| 136 | regulation of necroptotic process (GO:0060544) | 2.54473736 |
| 137 | positive regulation of lamellipodium organization (GO:1902745) | 2.54249137 |
| 138 | regulation of alpha-beta T cell proliferation (GO:0046640) | 2.54207395 |
| 139 | mature B cell differentiation involved in immune response (GO:0002313) | 2.52991922 |
| 140 | thymic T cell selection (GO:0045061) | 2.52436435 |
| 141 | regulation of interferon-gamma-mediated signaling pathway (GO:0060334) | 2.52265081 |
| 142 | translational termination (GO:0006415) | 2.48553701 |
| 143 | definitive hemopoiesis (GO:0060216) | 2.47828158 |
| 144 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 2.44847235 |
| 145 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.44037217 |
| 146 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.44031622 |
| 147 | myeloid dendritic cell differentiation (GO:0043011) | 2.41113829 |
| 148 | natural killer cell activation (GO:0030101) | 2.40773806 |
| 149 | production of molecular mediator involved in inflammatory response (GO:0002532) | 2.40616750 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | E2F7_22180533_ChIP-Seq_HELA_Human | 5.90354282 |
| 2 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.11369595 |
| 3 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.49208238 |
| 4 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.46801325 |
| 5 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.40965931 |
| 6 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.36409003 |
| 7 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.32837297 |
| 8 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.05488775 |
| 9 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.98154362 |
| 10 | * SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.83301647 |
| 11 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.80646549 |
| 12 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.69029809 |
| 13 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.65374739 |
| 14 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 2.62075253 |
| 15 | * RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.54530635 |
| 16 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.46944922 |
| 17 | * SPI1_23547873_ChIP-Seq_NB4_Human | 2.44859376 |
| 18 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.42774521 |
| 19 | MYC_22102868_ChIP-Seq_BL_Human | 2.38750095 |
| 20 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.35995579 |
| 21 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 2.35167664 |
| 22 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.34254701 |
| 23 | MYB_26560356_Chip-Seq_TH2_Human | 2.26978475 |
| 24 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.25894138 |
| 25 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.20749390 |
| 26 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.20414758 |
| 27 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.11574839 |
| 28 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 2.10977716 |
| 29 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 2.09173938 |
| 30 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 2.08292685 |
| 31 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 2.04103942 |
| 32 | MAF_26560356_Chip-Seq_TH1_Human | 2.02914565 |
| 33 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.94561311 |
| 34 | MYB_26560356_Chip-Seq_TH1_Human | 1.92663065 |
| 35 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.90739460 |
| 36 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.89328293 |
| 37 | * FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.88606809 |
| 38 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.86031341 |
| 39 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.85180863 |
| 40 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.81271881 |
| 41 | * UTX_26944678_Chip-Seq_JUKART_Human | 1.80085817 |
| 42 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.79706375 |
| 43 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.77652063 |
| 44 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.76558011 |
| 45 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.69474990 |
| 46 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.68993330 |
| 47 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.67945610 |
| 48 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.66384575 |
| 49 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 1.63561623 |
| 50 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.62825010 |
| 51 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.59806851 |
| 52 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.59455574 |
| 53 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.54964507 |
| 54 | * LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.54828456 |
| 55 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.47767614 |
| 56 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.47341604 |
| 57 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 1.46717632 |
| 58 | * GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.45057672 |
| 59 | * LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.43401164 |
| 60 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.40085766 |
| 61 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.38592941 |
| 62 | SPI1_23127762_ChIP-Seq_K562_Human | 1.34960575 |
| 63 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.32845254 |
| 64 | * E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.32754504 |
| 65 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.32687019 |
| 66 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.31425863 |
| 67 | GATA1_22025678_ChIP-Seq_K562_Human | 1.30885404 |
| 68 | MAF_26560356_Chip-Seq_TH2_Human | 1.29039219 |
| 69 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.26657568 |
| 70 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.26349875 |
| 71 | * GATA3_27048872_Chip-Seq_THYMUS_Human | 1.23506432 |
| 72 | * GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.23071773 |
| 73 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.22260419 |
| 74 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.21670111 |
| 75 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.20596611 |
| 76 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.19977759 |
| 77 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.19936452 |
| 78 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.16979463 |
| 79 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.16542240 |
| 80 | * GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.16537033 |
| 81 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.16025458 |
| 82 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.14690040 |
| 83 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.14646533 |
| 84 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.14229399 |
| 85 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.13433858 |
| 86 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.11327357 |
| 87 | * CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.09992000 |
| 88 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.08814170 |
| 89 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.05903519 |
| 90 | SPI1_20517297_ChIP-Seq_HL60_Human | 1.05865232 |
| 91 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.05347622 |
| 92 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.03976514 |
| 93 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.03482288 |
| 94 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.02938720 |
| 95 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.02878307 |
| 96 | * Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.02793367 |
| 97 | P300_27268052_Chip-Seq_Bcells_Human | 1.02587452 |
| 98 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.02539455 |
| 99 | GATA1_19941826_ChIP-Seq_K562_Human | 1.02392280 |
| 100 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.00675981 |
| 101 | * GATA3_26560356_Chip-Seq_TH2_Human | 1.00005816 |
| 102 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.99294490 |
| 103 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.98650226 |
| 104 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 0.98457012 |
| 105 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.97500238 |
| 106 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.96281017 |
| 107 | GABP_19822575_ChIP-Seq_HepG2_Human | 0.96198134 |
| 108 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 0.95283187 |
| 109 | DCP1A_22483619_ChIP-Seq_HELA_Human | 0.93939655 |
| 110 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 0.92335619 |
| 111 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.91330006 |
| 112 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.90944838 |
| 113 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.90778818 |
| 114 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 0.89620295 |
| 115 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 0.89427774 |
| 116 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 0.89181805 |
| 117 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 0.88937248 |
| 118 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.88818686 |
| 119 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.88590941 |
| 120 | * FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.87964691 |
| 121 | RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.87295076 |
| 122 | RBPJ_21746931_ChIP-Seq_IB4-LCL_Human | 0.87204907 |
| 123 | * GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.85549225 |
| 124 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.85405053 |
| 125 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.85189242 |
| 126 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 0.84451110 |
| 127 | RUNX1_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.81777506 |
| 128 | KDM2B_26808549_Chip-Seq_DND41_Human | 0.81058358 |
| 129 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 0.80771673 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0001835_abnormal_antigen_presentation | 4.16543366 |
| 2 | MP0005671_abnormal_response_to | 3.52998858 |
| 3 | MP0009785_altered_susceptibility_to | 3.52361613 |
| 4 | MP0003436_decreased_susceptibility_to | 3.14025102 |
| 5 | MP0002396_abnormal_hematopoietic_system | 3.11426530 |
| 6 | MP0003763_abnormal_thymus_physiology | 3.06306215 |
| 7 | MP0000685_abnormal_immune_system | 3.05719892 |
| 8 | MP0001800_abnormal_humoral_immune | 2.87540941 |
| 9 | MP0005025_abnormal_response_to | 2.85041952 |
| 10 | MP0005000_abnormal_immune_tolerance | 2.81717250 |
| 11 | MP0002148_abnormal_hypersensitivity_rea | 2.73240621 |
| 12 | MP0002419_abnormal_innate_immunity | 2.72708553 |
| 13 | * MP0002420_abnormal_adaptive_immunity | 2.67726829 |
| 14 | * MP0002452_abnormal_antigen_presenting | 2.64424516 |
| 15 | * MP0001819_abnormal_immune_cell | 2.64201417 |
| 16 | MP0002723_abnormal_immune_serum | 2.58244147 |
| 17 | MP0001790_abnormal_immune_system | 2.57484400 |
| 18 | MP0005387_immune_system_phenotype | 2.57484400 |
| 19 | MP0002166_altered_tumor_susceptibility | 2.51737766 |
| 20 | * MP0002398_abnormal_bone_marrow | 2.50254193 |
| 21 | MP0005464_abnormal_platelet_physiology | 2.41799077 |
| 22 | MP0003724_increased_susceptibility_to | 2.32135671 |
| 23 | * MP0000716_abnormal_immune_system | 2.22557995 |
| 24 | MP0002405_respiratory_system_inflammati | 2.19160126 |
| 25 | MP0009333_abnormal_splenocyte_physiolog | 2.13553960 |
| 26 | MP0002006_tumorigenesis | 2.11006192 |
| 27 | MP0003303_peritoneal_inflammation | 2.09061108 |
| 28 | MP0000689_abnormal_spleen_morphology | 2.08841983 |
| 29 | MP0004808_abnormal_hematopoietic_stem | 2.06315025 |
| 30 | MP0002722_abnormal_immune_system | 2.06127648 |
| 31 | MP0001853_heart_inflammation | 1.97196012 |
| 32 | * MP0002429_abnormal_blood_cell | 1.94384736 |
| 33 | MP0001545_abnormal_hematopoietic_system | 1.93520349 |
| 34 | MP0005397_hematopoietic_system_phenotyp | 1.93520349 |
| 35 | MP0010155_abnormal_intestine_physiology | 1.88550320 |
| 36 | MP0001873_stomach_inflammation | 1.83375520 |
| 37 | MP0006082_CNS_inflammation | 1.79875860 |
| 38 | MP0008057_abnormal_DNA_replication | 1.78911925 |
| 39 | MP0001845_abnormal_inflammatory_respons | 1.78207275 |
| 40 | MP0003693_abnormal_embryo_hatching | 1.77298017 |
| 41 | MP0000703_abnormal_thymus_morphology | 1.73412229 |
| 42 | MP0000465_gastrointestinal_hemorrhage | 1.71658070 |
| 43 | MP0000490_abnormal_crypts_of | 1.70184898 |
| 44 | MP0005174_abnormal_tail_pigmentation | 1.65648744 |
| 45 | MP0010094_abnormal_chromosome_stability | 1.63056764 |
| 46 | MP0000858_altered_metastatic_potential | 1.60940539 |
| 47 | MP0003806_abnormal_nucleotide_metabolis | 1.59009112 |
| 48 | MP0001533_abnormal_skeleton_physiology | 1.52228178 |
| 49 | MP0005075_abnormal_melanosome_morpholog | 1.51520553 |
| 50 | MP0004947_skin_inflammation | 1.48310612 |
| 51 | MP0003866_abnormal_defecation | 1.41753803 |
| 52 | MP0002933_joint_inflammation | 1.37051567 |
| 53 | MP0003172_abnormal_lysosome_physiology | 1.36329444 |
| 54 | MP0008469_abnormal_protein_level | 1.34029927 |
| 55 | MP0006054_spinal_hemorrhage | 1.32218181 |
| 56 | MP0003077_abnormal_cell_cycle | 1.30921146 |
| 57 | MP0003300_gastrointestinal_ulcer | 1.28972253 |
| 58 | MP0002019_abnormal_tumor_incidence | 1.25860516 |
| 59 | MP0009278_abnormal_bone_marrow | 1.23121629 |
| 60 | MP0002138_abnormal_hepatobiliary_system | 1.21217413 |
| 61 | MP0003111_abnormal_nucleus_morphology | 1.19540735 |
| 62 | MP0000343_altered_response_to | 1.19005499 |
| 63 | MP0003448_altered_tumor_morphology | 1.18209516 |
| 64 | MP0005058_abnormal_lysosome_morphology | 1.14052123 |
| 65 | MP0002095_abnormal_skin_pigmentation | 1.13097925 |
| 66 | MP0008058_abnormal_DNA_repair | 1.12295963 |
| 67 | MP0008007_abnormal_cellular_replicative | 1.09196790 |
| 68 | MP0000015_abnormal_ear_pigmentation | 1.07587900 |
| 69 | MP0002132_abnormal_respiratory_system | 1.07470316 |
| 70 | MP0003183_abnormal_peptide_metabolism | 1.06647208 |
| 71 | MP0005310_abnormal_salivary_gland | 1.04547425 |
| 72 | MP0010307_abnormal_tumor_latency | 1.03087474 |
| 73 | MP0004957_abnormal_blastocyst_morpholog | 1.00109697 |
| 74 | MP0009764_decreased_sensitivity_to | 0.97034416 |
| 75 | MP0001851_eye_inflammation | 0.95690157 |
| 76 | MP0010352_gastrointestinal_tract_polyps | 0.93013608 |
| 77 | MP0004510_myositis | 0.93001418 |
| 78 | MP0003656_abnormal_erythrocyte_physiolo | 0.92770037 |
| 79 | MP0003186_abnormal_redox_activity | 0.85698085 |
| 80 | MP0002277_abnormal_respiratory_mucosa | 0.84326628 |
| 81 | MP0000313_abnormal_cell_death | 0.83588556 |
| 82 | MP0009763_increased_sensitivity_to | 0.80916941 |
| 83 | MP0003191_abnormal_cellular_cholesterol | 0.74086716 |
| 84 | MP0008260_abnormal_autophagy | 0.72645723 |
| 85 | MP0003045_fibrosis | 0.72422911 |
| 86 | MP0005023_abnormal_wound_healing | 0.70357725 |
| 87 | MP0005084_abnormal_gallbladder_morpholo | 0.69999778 |
| 88 | MP0004883_abnormal_blood_vessel | 0.69740683 |
| 89 | MP0001663_abnormal_digestive_system | 0.69319106 |
| 90 | MP0005451_abnormal_body_composition | 0.67598316 |
| 91 | MP0002998_abnormal_bone_remodeling | 0.66756663 |
| 92 | MP0001986_abnormal_taste_sensitivity | 0.64951720 |
| 93 | MP0003075_altered_response_to | 0.63700571 |
| 94 | MP0002009_preneoplasia | 0.63389144 |
| 95 | MP0008004_abnormal_stomach_pH | 0.63267645 |
| 96 | MP0005390_skeleton_phenotype | 0.62505022 |
| 97 | MP0005166_decreased_susceptibility_to | 0.62120400 |
| 98 | MP0000371_diluted_coat_color | 0.60775984 |
| 99 | MP0006036_abnormal_mitochondrial_physio | 0.59396487 |
| 100 | MP0002693_abnormal_pancreas_physiology | 0.59121154 |
| 101 | MP0000604_amyloidosis | 0.57760537 |
| 102 | MP0003252_abnormal_bile_duct | 0.57660860 |
| 103 | MP0005645_abnormal_hypothalamus_physiol | 0.57547874 |
| 104 | MP0003943_abnormal_hepatobiliary_system | 0.56955114 |
| 105 | MP0003828_pulmonary_edema | 0.56804908 |
| 106 | MP0000249_abnormal_blood_vessel | 0.56494166 |
| 107 | MP0008873_increased_physiological_sensi | 0.56356207 |
| 108 | MP0003795_abnormal_bone_structure | 0.55359227 |
| 109 | MP0005164_abnormal_response_to | 0.54980750 |
| 110 | MP0005319_abnormal_enzyme/_coenzyme | 0.53976364 |
| 111 | MP0004381_abnormal_hair_follicle | 0.53464989 |
| 112 | MP0003786_premature_aging | 0.52166408 |
| 113 | MP0005165_increased_susceptibility_to | 0.51947452 |
| 114 | MP0000350_abnormal_cell_proliferation | 0.51116148 |
| 115 | MP0005167_abnormal_blood-brain_barrier | 0.50222274 |
| 116 | MP0001764_abnormal_homeostasis | 0.50189363 |
| 117 | MP0000477_abnormal_intestine_morphology | 0.49680942 |
| 118 | MP0009765_abnormal_xenobiotic_induced | 0.49645227 |
| 119 | MP0008874_decreased_physiological_sensi | 0.48320185 |
| 120 | MP0008872_abnormal_physiological_respon | 0.47336189 |
| 121 | MP0002136_abnormal_kidney_physiology | 0.46195080 |
| 122 | MP0009643_abnormal_urine_homeostasis | 0.45756678 |
| 123 | MP0001765_abnormal_ion_homeostasis | 0.44743651 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Recurrent abscess formation (HP:0002722) | 5.68031879 |
| 2 | Eczematoid dermatitis (HP:0000976) | 5.14793651 |
| 3 | Recurrent bacterial skin infections (HP:0005406) | 4.92584629 |
| 4 | Elevated erythrocyte sedimentation rate (HP:0003565) | 4.87047385 |
| 5 | Thrombocytosis (HP:0001894) | 4.52455147 |
| 6 | Myositis (HP:0100614) | 4.52032694 |
| 7 | IgM deficiency (HP:0002850) | 4.35057411 |
| 8 | Recurrent fungal infections (HP:0002841) | 3.99654439 |
| 9 | Recurrent viral infections (HP:0004429) | 3.86979727 |
| 10 | Chronic otitis media (HP:0000389) | 3.86689168 |
| 11 | Obstructive lung disease (HP:0006536) | 3.81727986 |
| 12 | Chronic obstructive pulmonary disease (HP:0006510) | 3.81727986 |
| 13 | Meningitis (HP:0001287) | 3.71046667 |
| 14 | Recurrent bronchitis (HP:0002837) | 3.63987495 |
| 15 | Mediastinal lymphadenopathy (HP:0100721) | 3.63512562 |
| 16 | Petechiae (HP:0000967) | 3.58248378 |
| 17 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.56874194 |
| 18 | Recurrent skin infections (HP:0001581) | 3.56085584 |
| 19 | Abnormality of T cells (HP:0002843) | 3.46758518 |
| 20 | Abnormality of T cell physiology (HP:0011840) | 3.40048706 |
| 21 | Cellulitis (HP:0100658) | 3.39297035 |
| 22 | Panhypogammaglobulinemia (HP:0003139) | 3.36326708 |
| 23 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.34473939 |
| 24 | Recurrent cutaneous fungal infections (HP:0011370) | 3.31740125 |
| 25 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.31740125 |
| 26 | Abnormality of macrophages (HP:0004311) | 3.27086242 |
| 27 | T lymphocytopenia (HP:0005403) | 3.26180630 |
| 28 | Abnormality of T cell number (HP:0011839) | 3.23640264 |
| 29 | Agammaglobulinemia (HP:0004432) | 3.17998174 |
| 30 | IgG deficiency (HP:0004315) | 3.10237876 |
| 31 | B lymphocytopenia (HP:0010976) | 3.09566687 |
| 32 | Abnormality of B cell number (HP:0010975) | 3.09566687 |
| 33 | Gastrointestinal infarctions (HP:0005244) | 3.09253593 |
| 34 | Orchitis (HP:0100796) | 3.07501077 |
| 35 | Aplastic anemia (HP:0001915) | 3.02666831 |
| 36 | Lymphopenia (HP:0001888) | 3.00551172 |
| 37 | Vasculitis (HP:0002633) | 3.00407624 |
| 38 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.94561595 |
| 39 | Stomatitis (HP:0010280) | 2.89793256 |
| 40 | Retrobulbar optic neuritis (HP:0100654) | 2.89589768 |
| 41 | Optic neuritis (HP:0100653) | 2.89589768 |
| 42 | Severe combined immunodeficiency (HP:0004430) | 2.87725991 |
| 43 | Thyroiditis (HP:0100646) | 2.82408833 |
| 44 | Leukocytosis (HP:0001974) | 2.82386755 |
| 45 | Eosinophilia (HP:0001880) | 2.81544254 |
| 46 | Abnormality of the prostate (HP:0008775) | 2.80226748 |
| 47 | Granulocytopenia (HP:0001913) | 2.76072590 |
| 48 | Combined immunodeficiency (HP:0005387) | 2.73783923 |
| 49 | Autoimmune thrombocytopenia (HP:0001973) | 2.73162721 |
| 50 | Abnormality of eosinophils (HP:0001879) | 2.70090735 |
| 51 | Encephalitis (HP:0002383) | 2.69435769 |
| 52 | Spontaneous hematomas (HP:0007420) | 2.67109700 |
| 53 | Purpura (HP:0000979) | 2.65702748 |
| 54 | Prolonged bleeding time (HP:0003010) | 2.61752385 |
| 55 | Periodontitis (HP:0000704) | 2.61403293 |
| 56 | Gingivitis (HP:0000230) | 2.60133646 |
| 57 | Epistaxis (HP:0000421) | 2.59154155 |
| 58 | Reticulocytopenia (HP:0001896) | 2.55410711 |
| 59 | Hypergammaglobulinemia (HP:0010702) | 2.54879553 |
| 60 | Nasal polyposis (HP:0100582) | 2.51800756 |
| 61 | Pustule (HP:0200039) | 2.49869952 |
| 62 | Reduced antithrombin III activity (HP:0001976) | 2.47960095 |
| 63 | Inflammation of the large intestine (HP:0002037) | 2.47185767 |
| 64 | Recurrent sinusitis (HP:0011108) | 2.44155781 |
| 65 | Vacuolated lymphocytes (HP:0001922) | 2.44112245 |
| 66 | Abnormality of the pleura (HP:0002103) | 2.43919573 |
| 67 | Keratoconjunctivitis sicca (HP:0001097) | 2.43760764 |
| 68 | Gastrointestinal inflammation (HP:0004386) | 2.43012495 |
| 69 | Lymphoma (HP:0002665) | 2.42880665 |
| 70 | Pulmonary infiltrates (HP:0002113) | 2.42878158 |
| 71 | Pulmonary embolism (HP:0002204) | 2.41785409 |
| 72 | Hemoptysis (HP:0002105) | 2.40104376 |
| 73 | Recurrent pneumonia (HP:0006532) | 2.39498595 |
| 74 | Acute hepatic failure (HP:0006554) | 2.38035833 |
| 75 | Chest pain (HP:0100749) | 2.34350589 |
| 76 | Osteomyelitis (HP:0002754) | 2.33978281 |
| 77 | Recurrent lower respiratory tract infections (HP:0002783) | 2.31968327 |
| 78 | Urticaria (HP:0001025) | 2.29311112 |
| 79 | Gastrointestinal stroma tumor (HP:0100723) | 2.28374875 |
| 80 | Gangrene (HP:0100758) | 2.27973532 |
| 81 | Abnormality of the nasal mucosa (HP:0000433) | 2.25082003 |
| 82 | Chronic diarrhea (HP:0002028) | 2.24583124 |
| 83 | Sepsis (HP:0100806) | 2.23088937 |
| 84 | Abnormal number of erythroid precursors (HP:0012131) | 2.23037638 |
| 85 | Poikiloderma (HP:0001029) | 2.22232058 |
| 86 | Neutropenia (HP:0001875) | 2.21841160 |
| 87 | Keratoconjunctivitis (HP:0001096) | 2.21399420 |
| 88 | Increased IgM level (HP:0003496) | 2.21397150 |
| 89 | Verrucae (HP:0200043) | 2.20941202 |
| 90 | Papilloma (HP:0012740) | 2.20941202 |
| 91 | Joint swelling (HP:0001386) | 2.20597694 |
| 92 | IgA deficiency (HP:0002720) | 2.20461550 |
| 93 | Hepatosplenomegaly (HP:0001433) | 2.20382716 |
| 94 | Interstitial pulmonary disease (HP:0006530) | 2.20055248 |
| 95 | Autoimmune hemolytic anemia (HP:0001890) | 2.19939543 |
| 96 | Arterial thrombosis (HP:0004420) | 2.19128640 |
| 97 | Type I transferrin isoform profile (HP:0003642) | 2.17766849 |
| 98 | Skin ulcer (HP:0200042) | 2.16817401 |
| 99 | Hypoproteinemia (HP:0003075) | 2.16392207 |
| 100 | Hypochromic anemia (HP:0001931) | 2.16080742 |
| 101 | Abnormality of cells of the erythroid lineage (HP:0012130) | 2.14426901 |
| 102 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.12778510 |
| 103 | Increased serum ferritin (HP:0003281) | 2.12755806 |
| 104 | Increased cerebral lipofuscin (HP:0011813) | 2.12313074 |
| 105 | Anorexia (HP:0002039) | 2.12213340 |
| 106 | Hypoplasia of the thymus (HP:0000778) | 2.11944335 |
| 107 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 2.08507885 |
| 108 | Abnormality of iron homeostasis (HP:0011031) | 2.08104398 |
| 109 | Episodic fever (HP:0001954) | 2.06748844 |
| 110 | Abnormality of the fingertips (HP:0001211) | 2.06558828 |
| 111 | Abnormal platelet volume (HP:0011876) | 2.05193452 |
| 112 | Abnormal platelet function (HP:0011869) | 2.03347583 |
| 113 | Impaired platelet aggregation (HP:0003540) | 2.03347583 |
| 114 | Gingival bleeding (HP:0000225) | 2.03005804 |
| 115 | Prostate neoplasm (HP:0100787) | 2.02072013 |
| 116 | Increased IgE level (HP:0003212) | 2.01451921 |
| 117 | Pulmonary fibrosis (HP:0002206) | 2.01107736 |
| 118 | Skin rash (HP:0000988) | 2.00161366 |
| 119 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 2.00013451 |
| 120 | Amaurosis fugax (HP:0100576) | 1.99658135 |
| 121 | Basal ganglia calcification (HP:0002135) | 1.97760551 |
| 122 | Colitis (HP:0002583) | 1.96937660 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP4K1 | 4.39740442 |
| 2 | TXK | 3.37796499 |
| 3 | IRAK4 | 3.17076829 |
| 4 | KIT | 2.71366956 |
| 5 | BLK | 2.63681448 |
| 6 | BTK | 2.52747700 |
| 7 | TEC | 2.51874978 |
| 8 | ZAP70 | 2.40497397 |
| 9 | JAK3 | 2.08542333 |
| 10 | TBK1 | 1.96893057 |
| 11 | TYK2 | 1.96637023 |
| 12 | IKBKE | 1.95115433 |
| 13 | SYK | 1.93762135 |
| 14 | MAP3K14 | 1.87428090 |
| 15 | STK10 | 1.83055951 |
| 16 | TESK2 | 1.79961854 |
| 17 | NME2 | 1.78545347 |
| 18 | FLT3 | 1.77038758 |
| 19 | ITK | 1.74917167 |
| 20 | KDR | 1.69209848 |
| 21 | MAP3K12 | 1.67928148 |
| 22 | CSF1R | 1.67015448 |
| 23 | CLK1 | 1.60767548 |
| 24 | PIM2 | 1.59633414 |
| 25 | BCKDK | 1.51076506 |
| 26 | MAP2K3 | 1.40820627 |
| 27 | TAOK3 | 1.38897545 |
| 28 | LCK | 1.37158274 |
| 29 | CDC7 | 1.36646572 |
| 30 | ERN1 | 1.36237195 |
| 31 | STK16 | 1.35260002 |
| 32 | GRK6 | 1.35190789 |
| 33 | BMPR2 | 1.34651117 |
| 34 | WEE1 | 1.34614253 |
| 35 | RIPK4 | 1.34541771 |
| 36 | FES | 1.32713044 |
| 37 | LYN | 1.30737755 |
| 38 | ACVR1B | 1.28136523 |
| 39 | EEF2K | 1.25948045 |
| 40 | HCK | 1.24717041 |
| 41 | CSK | 1.23858769 |
| 42 | MAP3K13 | 1.23779347 |
| 43 | LRRK2 | 1.22645227 |
| 44 | VRK2 | 1.21731365 |
| 45 | EIF2AK1 | 1.18944832 |
| 46 | IKBKB | 1.17102692 |
| 47 | PIM1 | 1.12731716 |
| 48 | RPS6KA4 | 1.11980083 |
| 49 | EIF2AK3 | 1.11770530 |
| 50 | BRSK2 | 1.06949150 |
| 51 | JAK1 | 1.02286155 |
| 52 | NLK | 1.00612665 |
| 53 | BUB1 | 1.00397395 |
| 54 | IRAK3 | 0.92585430 |
| 55 | TGFBR1 | 0.92208290 |
| 56 | PRPF4B | 0.87013170 |
| 57 | GRK7 | 0.86947016 |
| 58 | STK4 | 0.86469162 |
| 59 | NUAK1 | 0.85004121 |
| 60 | TESK1 | 0.82556435 |
| 61 | FGR | 0.82027360 |
| 62 | TRPM7 | 0.81059156 |
| 63 | TNK2 | 0.79502005 |
| 64 | PKN2 | 0.78818450 |
| 65 | VRK1 | 0.76978408 |
| 66 | NEK2 | 0.76093186 |
| 67 | ATR | 0.74292062 |
| 68 | TGFBR2 | 0.74018687 |
| 69 | MAP3K3 | 0.69042092 |
| 70 | MARK3 | 0.65811851 |
| 71 | MATK | 0.65038353 |
| 72 | MST4 | 0.64039119 |
| 73 | RPS6KA6 | 0.63980005 |
| 74 | MAP2K6 | 0.63137831 |
| 75 | MAP3K10 | 0.62627548 |
| 76 | TLK1 | 0.60988622 |
| 77 | CDK4 | 0.60663717 |
| 78 | RPS6KB2 | 0.60528879 |
| 79 | FYN | 0.60029232 |
| 80 | PDK1 | 0.59825598 |
| 81 | FGFR3 | 0.58564959 |
| 82 | MAP3K1 | 0.58032065 |
| 83 | FGFR4 | 0.55097355 |
| 84 | RPS6KC1 | 0.54319483 |
| 85 | RPS6KL1 | 0.54319483 |
| 86 | PAK4 | 0.54135663 |
| 87 | MAPKAPK3 | 0.53649351 |
| 88 | NEK9 | 0.53630920 |
| 89 | EPHB1 | 0.53523350 |
| 90 | CDK7 | 0.53245074 |
| 91 | CDK19 | 0.53012261 |
| 92 | CHUK | 0.52951637 |
| 93 | SIK3 | 0.52651792 |
| 94 | MAPK4 | 0.52104901 |
| 95 | TAOK2 | 0.51689088 |
| 96 | MAP3K8 | 0.49827948 |
| 97 | CDK8 | 0.48313229 |
| 98 | MAP3K11 | 0.47208317 |
| 99 | PIK3CG | 0.46789958 |
| 100 | MAPK11 | 0.46623955 |
| 101 | MAPK12 | 0.46515143 |
| 102 | ADRBK2 | 0.45859945 |
| 103 | JAK2 | 0.45809441 |
| 104 | BRSK1 | 0.45543281 |
| 105 | PRKCD | 0.45454653 |
| 106 | MAP3K5 | 0.44958620 |
| 107 | PRKCQ | 0.44841062 |
| 108 | PASK | 0.44117138 |
| 109 | SCYL2 | 0.43651742 |
| 110 | CAMKK1 | 0.43413108 |
| 111 | MAPKAPK2 | 0.42837525 |
| 112 | DAPK1 | 0.42315578 |
| 113 | MYLK | 0.42081675 |
| 114 | CCNB1 | 0.41338687 |
| 115 | ZAK | 0.40615458 |
| 116 | EIF2AK2 | 0.39591541 |
| 117 | CAMKK2 | 0.38764794 |
| 118 | ILK | 0.38227291 |
| 119 | GRK5 | 0.38175157 |
| 120 | SRPK1 | 0.38159934 |
| 121 | HIPK2 | 0.37273139 |
| 122 | ABL1 | 0.36759840 |
| 123 | MAP4K2 | 0.36591388 |
| 124 | PRKG2 | 0.36126607 |
| 125 | TAOK1 | 0.34822328 |
| 126 | IGF1R | 0.34271185 |
| 127 | PTK2B | 0.33573823 |
| 128 | IRAK1 | 0.32966015 |
| 129 | SIK2 | 0.32103171 |
| 130 | MAP2K2 | 0.31928329 |
| 131 | RPS6KA5 | 0.31038529 |
| 132 | MAPK7 | 0.27521366 |
| 133 | MAPK3 | 0.24861336 |
| 134 | ADRBK1 | 0.19713797 |
| 135 | SMG1 | 0.19240372 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary immunodeficiency_Homo sapiens_hsa05340 | 3.63843155 |
| 2 | DNA replication_Homo sapiens_hsa03030 | 3.22716984 |
| 3 | Leishmaniasis_Homo sapiens_hsa05140 | 2.60146960 |
| 4 | Antigen processing and presentation_Homo sapiens_hsa04612 | 2.30262647 |
| 5 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 2.25372922 |
| 6 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 2.24545161 |
| 7 | Mismatch repair_Homo sapiens_hsa03430 | 2.23866209 |
| 8 | Ribosome_Homo sapiens_hsa03010 | 2.20182777 |
| 9 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.19121123 |
| 10 | Measles_Homo sapiens_hsa05162 | 2.09596269 |
| 11 | Base excision repair_Homo sapiens_hsa03410 | 2.06622822 |
| 12 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.02483773 |
| 13 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.02096235 |
| 14 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.00852274 |
| 15 | Allograft rejection_Homo sapiens_hsa05330 | 1.92057298 |
| 16 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.87751930 |
| 17 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.86826621 |
| 18 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.72790178 |
| 19 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.71709281 |
| 20 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.71503614 |
| 21 | Homologous recombination_Homo sapiens_hsa03440 | 1.69808684 |
| 22 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.67364425 |
| 23 | Proteasome_Homo sapiens_hsa03050 | 1.52333850 |
| 24 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.48484378 |
| 25 | Legionellosis_Homo sapiens_hsa05134 | 1.48006118 |
| 26 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.47753434 |
| 27 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.47359527 |
| 28 | Shigellosis_Homo sapiens_hsa05131 | 1.38119227 |
| 29 | Asthma_Homo sapiens_hsa05310 | 1.35102273 |
| 30 | Other glycan degradation_Homo sapiens_hsa00511 | 1.34000609 |
| 31 | Pertussis_Homo sapiens_hsa05133 | 1.33752228 |
| 32 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.30682793 |
| 33 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.29805988 |
| 34 | Spliceosome_Homo sapiens_hsa03040 | 1.29280561 |
| 35 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.25468044 |
| 36 | Tuberculosis_Homo sapiens_hsa05152 | 1.22208904 |
| 37 | Influenza A_Homo sapiens_hsa05164 | 1.19334030 |
| 38 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 1.18955434 |
| 39 | Malaria_Homo sapiens_hsa05144 | 1.18335638 |
| 40 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.18127259 |
| 41 | Viral myocarditis_Homo sapiens_hsa05416 | 1.18122739 |
| 42 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 1.16882850 |
| 43 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 1.16587950 |
| 44 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.15410500 |
| 45 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.14055206 |
| 46 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.14029372 |
| 47 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.12733904 |
| 48 | Hepatitis B_Homo sapiens_hsa05161 | 1.12173890 |
| 49 | Apoptosis_Homo sapiens_hsa04210 | 1.10717582 |
| 50 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.09155936 |
| 51 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.07157446 |
| 52 | Cell cycle_Homo sapiens_hsa04110 | 1.05575078 |
| 53 | Salmonella infection_Homo sapiens_hsa05132 | 0.99977170 |
| 54 | RNA polymerase_Homo sapiens_hsa03020 | 0.98541669 |
| 55 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.98002445 |
| 56 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.97423360 |
| 57 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.96902928 |
| 58 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.96376425 |
| 59 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.96287484 |
| 60 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.95805044 |
| 61 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.93440063 |
| 62 | Platelet activation_Homo sapiens_hsa04611 | 0.93042868 |
| 63 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.92323161 |
| 64 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.90556431 |
| 65 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.89316669 |
| 66 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.89254496 |
| 67 | Protein export_Homo sapiens_hsa03060 | 0.86675526 |
| 68 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.83413176 |
| 69 | RNA degradation_Homo sapiens_hsa03018 | 0.82991658 |
| 70 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.74379891 |
| 71 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.74363393 |
| 72 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.72981996 |
| 73 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.72083746 |
| 74 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.71585005 |
| 75 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.70898873 |
| 76 | HTLV-I infection_Homo sapiens_hsa05166 | 0.68499620 |
| 77 | RNA transport_Homo sapiens_hsa03013 | 0.66183297 |
| 78 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.65888085 |
| 79 | Lysosome_Homo sapiens_hsa04142 | 0.64885452 |
| 80 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.59623466 |
| 81 | Phagosome_Homo sapiens_hsa04145 | 0.58509284 |
| 82 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.57971484 |
| 83 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.57256909 |
| 84 | Hepatitis C_Homo sapiens_hsa05160 | 0.56596635 |
| 85 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.54139520 |
| 86 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.53465638 |
| 87 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.51290075 |
| 88 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.50955170 |
| 89 | Basal transcription factors_Homo sapiens_hsa03022 | 0.50888546 |
| 90 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.50335839 |
| 91 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.50084046 |
| 92 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.48551903 |
| 93 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.47538992 |
| 94 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.46623681 |
| 95 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.45937639 |
| 96 | Purine metabolism_Homo sapiens_hsa00230 | 0.45244367 |
| 97 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.41954373 |
| 98 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.40312280 |
| 99 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.39861861 |
| 100 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.38418454 |
| 101 | Endocytosis_Homo sapiens_hsa04144 | 0.36477207 |
| 102 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.36418380 |
| 103 | Galactose metabolism_Homo sapiens_hsa00052 | 0.34845521 |
| 104 | Colorectal cancer_Homo sapiens_hsa05210 | 0.34451122 |
| 105 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.32905114 |
| 106 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.26266623 |
| 107 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.24565334 |
| 108 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.22662216 |
| 109 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.22005404 |
| 110 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.21914567 |
| 111 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.21754426 |
| 112 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.20809657 |
| 113 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.20149637 |
| 114 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.19357003 |
| 115 | Parkinsons disease_Homo sapiens_hsa05012 | 0.17471190 |
| 116 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.16739175 |
| 117 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.14449874 |
| 118 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.13370843 |
| 119 | Peroxisome_Homo sapiens_hsa04146 | 0.12871436 |
| 120 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.12111066 |
| 121 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.11790594 |
| 122 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.11697507 |
| 123 | Olfactory transduction_Homo sapiens_hsa04740 | 0.09637202 |
| 124 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.08123583 |
| 125 | Phototransduction_Homo sapiens_hsa04744 | 0.07525308 |
| 126 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.05576312 |
| 127 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.04197122 |
| 128 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.03671557 |
| 129 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.03175490 |

